Biomedicines (Dec 2020)

Modulation of Early Host Innate Immune Response by an Avipox Vaccine Virus’ Lateral Body Protein

  • Efstathios S. Giotis,
  • Stephen M. Laidlaw,
  • Susanna R. Bidgood,
  • David Albrecht,
  • Jemima J. Burden,
  • Rebecca C. Robey,
  • Jason Mercer,
  • Michael A. Skinner

DOI
https://doi.org/10.3390/biomedicines8120634
Journal volume & issue
Vol. 8, no. 12
p. 634

Abstract

Read online

The avian pathogen fowlpox virus (FWPV) has been successfully used as a vaccine vector in poultry and humans, but relatively little is known about its ability to modulate host antiviral immune responses in these hosts, which are replication-permissive and nonpermissive, respectively. FWPV is highly resistant to avian type I interferon (IFN) and able to completely block the host IFN-response. Microarray screening of host IFN-regulated gene expression in cells infected with 59 different, nonessential FWPV gene knockout mutants revealed that FPV184 confers immunomodulatory capacity. We report that the FPV184-knockout virus (FWPVΔ184) induces the cellular IFN response as early as 2 h postinfection. The wild-type, uninduced phenotype can be rescued by transient expression of FPV184 in FWPVΔ184-infected cells. Ectopic expression of FPV184 inhibited polyI:C activation of the chicken IFN-β promoter and IFN-α activation of the chicken Mx1 promoter. Confocal and correlative super-resolution light and electron microscopy demonstrated that FPV184 has a functional nuclear localisation signal domain and is packaged in the lateral bodies of the virions. Taken together, these results provide a paradigm for a late poxvirus structural protein packaged in the lateral bodies, capable of suppressing IFN induction early during the next round of infection.

Keywords